Département de Génétique Médicale, Hôpital Arnaud de Villeneuve, Montpellier, France.
Equipe GAD, UMR1231, Université de Bourgogne Franche Comté, Dijon, France.
Am J Med Genet A. 2018 Dec;176(12):2813-2818. doi: 10.1002/ajmg.a.40510. Epub 2018 Oct 26.
Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole-exome sequencing. A dominant-negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont-like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont-like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.
皮尔彭特综合征是一种罕见且散发性的综合征,包括发育迟缓、面部特征和四肢异常。最近,通过全外显子组测序在 8 名患者中发现了一种反复出现的 TBL1XR1 变异(c.1337A>G;p.Tyr446Cys)。由于 TBL1XR1 缺失和其他预测功能丧失的变异的患者并不具有相同的表型,因此强烈怀疑该突变具有显性负效应。我们报告了两例具有典型皮尔彭特样综合征特征的患者。外显子组测序在两名患者中均发现了一种新的杂合错义 TBL1XR1 变异,与已报道的变异不同:p.Cys325Tyr 和 p.Tyr446His。这些突变的定位和皮尔彭特样综合征的临床特征表明,其功能后果与先前描述的反复突变相当,并提供了额外的数据来理解 TBL1XR1 异常的分子机制。